Novacyt announces launch of COVID-19 antibody test

PARIS: Novacyt S.A, an international specialist in clinical diagnostics, has launched a CE-Mark approved serology (antibody) 96-well plate ELISA (enzyme-linked immunosorbent assay) test for the detection of IgG antibodies to SARS-CoV-2 derived from plasma and serum samples. The test has been launched by Microgen Bioproducts Limited (Microgen), which is part of Novacyt’s protein diagnostics division…

Novacyt launches two gene COVID-19 test

Novacyt launches two gene COVID-19 test

PARIS: Novacyt S.A, an international specialist in clinical diagnostics, has launched a CE-Mark approved polymerase chain reaction (PCR) two gene target test for COVID-19. The test, which provides an additional option to the Company’s successful single gene test, addresses the need of a number of countries which require a two gene target testing approach for…

Novacyt launches novel coronavirus test

PARIS: Novacyt S.A, an international specialist in clinical diagnostics, announced that its molecular diagnostics division, Primerdesign, has launched a new molecular test for novel coronavirus (2019-nCoV). As announced on 28 January, the research use only (RUO) test has been developed as a direct response to the recent outbreak of the respiratory virus in China. The…